CHANTAL PHARMACEUTICAL CORPORATION – Trademark Portfolio
Entity Type: 03
CHANTAL PHARMACEUTICAL CORPORATION holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CP. The owner is based in LOS ANGELES, CA.
19TH FLOOR
10880 WILSHIRE BOULEVARD
LOS ANGELES, CA 90024
Showing of trademarks Trademarks
Trademark Classifications
CHANTAL PHARMACEUTICAL CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does CHANTAL PHARMACEUTICAL CORPORATION have?
CHANTAL PHARMACEUTICAL CORPORATION has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 2 cancelled.
What trademark classes does CHANTAL PHARMACEUTICAL CORPORATION file in?
CHANTAL PHARMACEUTICAL CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CHANTAL PHARMACEUTICAL CORPORATION's most well-known trademarks?
CHANTAL PHARMACEUTICAL CORPORATION's registered trademark portfolio includes well-known marks such as CP. These are among 1 currently registered trademark in the portfolio.
What is CHANTAL PHARMACEUTICAL CORPORATION's trademark registration success rate?
CHANTAL PHARMACEUTICAL CORPORATION has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.